Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Daidzein Tablets

Approval Number

国药准字H11022303

Company华润双鹤药业股份有限公司

Registration Date

December 11, 2020

Previous Approval Numbers

国药准字H11022303

Drug Information

Generic Name

黄豆苷元片

Dosage Form

片剂

Strength

25mg

Drug Type

化学药品

Registration Date

December 11, 2020

Company Information

Applicant Company

Company Name华润双鹤药业股份有限公司

Company Address

北京市朝阳区望京利泽东二路1号

Manufacturing Company

Company Name北京万辉双鹤药业有限责任公司

Company Address

北京市门头沟区石龙经济开发区上园路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy